title: Metabolic and hormonal responses during repeated bouts of brief and intense exercise: effects of pre-exercise glucose ingestion.
abstract: We investigated metabolic and hormonal responses during repeated bouts of brief and intense exercise (a force-velocity test; Fv test) and examined the effect of glucose ingestion on these responses and on exercise performance. The test was performed twice by seven subjects [27 (2) years] according to a double-blind randomized crossover protocol. During the experimental trial (GLU), the subjects ingested 500 ml of glucose polymer solution containing 25 g glucose 15 min before starting the exercise. During the control trial (CON), the subjects received an equal volume of sweet placebo (aspartame). Exercise performance was assessed by calculating peak anaerobic power (W(an,peak)). Venous plasma lactate concentration increased significantly during the Fv test (P < 0.001), but no difference was found between CON and GLU. Blood glucose first decreased significantly from the beginning of exercise up to the 6-kg load (P < 0.001) and then increased significantly at W(an,peak) and for up to 10 min during the recovery period (P < 0.001) in both CON and GLU. Insulin concentrations decreased significantly in both groups, but were higher at W(an,peak) in GLU compared with CON (P < 0.05). Glucagon and epinephrine did not change significantly in either group, but epinephrine was significantly lower in GLU after glucose ingestion (P < 0.05) and at W(an,peak) (P < 0.05). W(an,peak) was not significantly different between CON and GLU. In conclusion, blood glucose and insulin concentrations decreased during repeated bouts of brief and intense exercise, while blood lactate concentration increased markedly without any significant change in glucagon and epinephrine concentrations. Glucose ingestion altered metabolic and hormonal responses during the Fv test, but the performance as measured by W(an,peak) was not changed.
authors.affiliation: Laboratoire de Physiologie des Interactions, Hôpital Arnaud de Villeneuve, Montpellier, France.
authors.forename: D
authors.initials: D
authors.lastname: Wouassi
authors.forename: J
authors.initials: J
authors.lastname: Mercier
authors.forename: S
authors.initials: S
authors.lastname: Ahmaidi
authors.forename: J F
authors.initials: JF
authors.lastname: Brun
authors.forename: B
authors.initials: B
authors.lastname: Mercier
authors.forename: A
authors.initials: A
authors.lastname: Orsetti
authors.forename: C
authors.initials: C
authors.lastname: Préfaut
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004837:Epinephrine / Q000097:blood*; D015444:Exercise / Q000502:physiology*; D005934:Glucagon / Q000097:blood*; D005947:Glucose / Q000008:administration & dosage*; D006706:Homeostasis; D006801:Humans; D007328:Insulin / Q000097:blood*; D007700:Kinetics; D019344:Lactic Acid / Q000097:blood; D008297:Male; D010919:Placebos
chemical_list: D001786:Blood Glucose; D007328:Insulin; D010919:Placebos; D019344:Lactic Acid; D005934:Glucagon; D005947:Glucose; D004837:Epinephrine